Sheila Ranganath
Private Equity Investor chez Flagship Pioneering
Profil
Sheila Ranganath joined Flagship Pioneering in 2022 as Vice President of Program Leadership for Pioneering Medicines.
She is responsible for leading multidisciplinary teams and collaborations between Pioneering Medicines, Flagship platform companies, and external partners for early discovery through early clinical development stage programs.
Sheila brings over 15 years of industry experience from biotech and pharma to Pioneering Medicines.
Prior to joining Flagship, she was Vice President, Biology at LifeMine Therapeutics where she led the Discovery and Translational Biology group and oversaw the New Target Evaluation team.
Previously, she was Director, Immunobiology in the Discovery Oncology group at Merck where she supported Keytruda combination strategy; led several multidisciplinary teams to develop drug candidates in different modalities; oversaw and supported several early clinical development programs; and led academic collaborations.
Prior to Merck, Sheila she spent ten years in positions of increasing responsibility at Pfizer, Ironwood Pharmaceuticals, and Enumeral Biomedical.
Sheila has co-authored over 25 publications and contributed to articles published in Nature, Immunity, and the Journal of Immunology.
Sheila received a B.A.
in Molecular and Cellular Biology from the University of California, Berkeley, a Ph.D.
in Immunology from Washington University in St. Louis and completed postdoctoral training at Harvard Medical School.
Postes actifs de Sheila Ranganath
| Sociétés | Poste | Début |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/04/2022 |
Anciens postes connus de Sheila Ranganath
| Sociétés | Poste | Fin |
|---|---|---|
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Private Equity Investor | 02/03/2022 |
| MERCK & CO., INC. | Private Equity Investor | 02/04/2021 |
| ENUMERAL BIOMEDICAL HOLDINGS INC | Private Equity Investor | 02/08/2016 |
| PFIZER, INC. | Corporate Officer/Principal | 02/04/2011 |
Formation de Sheila Ranganath
| University of Washington | Doctorate Degree |
| University of California | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Enumeral Biomedical Holdings, Inc.
 Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Enumeral Biomedical Holdings, Inc. is a biopharmaceutical company, which engages in the business of discovering and developing novel antibody immunotherapies for the treatment of cancer and other diseases. It also focuses on the development of a pipeline of next generation monoclonal antibody drugs targeting established and novel immuno-modulatory receptors. The company was founded by Barry C. Buckland, John J. Rydzewski, and Arthur H. Tinkelenberg on December 11, 2009 and is headquartered in Arlington, MA. | Health Technology |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
LifeMine Therapeutics, Inc.
LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Health Technology |
